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DOI: 10.1039/c1sm05793fThis study demonstrates the feasibility of additive manufactured poly(3-caprolactone)/silanized
tricalcium phosphate (PCL/TCP(Si)) scaffolds coated with carbonated hydroxyapatite (CHA)-gelatin
composite for bone tissue engineering. In order to reinforce PCL/TCP scaffolds to match the
mechanical properties of cancellous bone, TCP has been modified with 3-glycidoxypropyl
trimethoxysilane (GPTMS) and incorporated into PCL to synthesize a PCL/TCP(Si) composite. The
successful modification is confirmed by X-ray photoelectron spectroscopy (XPS) and Fourier
transform infrared spectroscopy (FTIR) analysis. Additive manufactured PCL/TCP(Si) scaffolds have
been fabricated using a screw extrusion system (SES). Compression testing demonstrates that both the
compressive modulus and compressive yield strength of the developed PCL/TCP(Si) scaffolds fall
within the lower ranges of mechanical properties for cancellous bone, with a compressive modulus and
compressive yield strength of 6.0 times and 2.3 times of those of PCL/TCP scaffolds, respectively. To
enhance the osteoconductive property of the developed PCL/TCP(Si) scaffolds, a CHA-gelatin
composite has been coated onto the scaffolds via a biomimetic co-precipitation process, which is
verified by using scanning electron microscopy (SEM) and XPS. Confocal laser microscopy and SEM
images reveal a most uniform distribution of porcine bone marrow stromal cells (BMSCs) and cell-
sheet accumulation on the CHA-gelatin composite coated PCL/TCP(Si) scaffolds. The proliferation
rate of BMSCs on the CHA-gelatin composite coated PCL/TCP(Si) scaffolds is 2.0 and 1.4 times higher
compared to PCL/TCP(Si) and CHA coated PCL/TCP(Si) scaffolds, respectively, by day 10.
Furthermore, the reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses
reveal that CHA-gelatin composite coated PCL/TCP(Si) scaffolds stimulate osteogenic differentiation
of BMSCs the most compared to the other scaffolds. In vitro results of SEM, confocal microscopy and
proliferation rate also show that there is no detrimental effect of GPTMS modification on
biocompatibility of the scaffolds.Introduction
Despite the high regenerative capacity of bone, large bone defects
due to high energy trauma, bone tumor resections, congenital
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This journal is ª The Royal Society of Chemistry 2011substitute for regeneration, which is about 10% of all ortho-
paedic operations worldwide.1 Common clinical bone substitutes
include xenograft, allograft and autogenous cancellous bone
graft from the ilium, chest or tibial tuberosity. Autogenous
cancellous bone graft is the most common bone substitute
because of its biological properties and lack of possibility of
disease transmission or host rejection.2 Nevertheless, its use is
severely hampered by its short supply, temporary disruption of
the donor site bone structure and considerable donor site
morbidity associated with the harvest.2,3 Therefore, the devel-
opment of a new synthetic bone substitute or scaffold that could
be used instead of autogenous cancellous bone graft, has become
a key research topic in bone tissue engineering.4–7
An ideal scaffold aims to mimic the mechanical and
biochemical properties of the native tissue. Therefore, one
fundamental hypothesis is to design the scaffold to provide
a biomimetic mechanical environment to withstand in vivo stressSoft Matter
Fig. 1 Schematic diagram of TCP modification and PCL/TCP(Si)
composite preparation.
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View Onlineand loading.8 Specifically, it was proposed that the implanted
scaffold should match the stiffness and strength of native
tissue,6,7 which ranges from 50 to 500 MPa and 3 to 12 MPa for
cancellous bone, respectively.9,10
Additive manufacturing (AM) technology, also known as rapid
prototyping (RP), is a computer controlled fabrication process and
holds the key for a generic solution in automating scaffolds
production because of its consistency and high reproducibility. It
has great potential over conventional manual-based fabrication
techniques, as the scaffolds fabricated by AM are design depen-
dent, whereas the scaffolds fabricated by conventional techniques
are highly process dependent.11 Poly(3-caprolactone) (PCL) is
a bioresorbable and thermoplastic aliphatic polyester, and has been
used preferably to fabricate scaffolds with AM technology because
it is easy to form at relatively low temperature and has good melt
viscosity.12–15 In order to increase the mechanical properties and
bioactivity of these PCL scaffolds, pristine ceramic particles such as
hydroxyapatite (HA) and tricalcium phosphate (TCP) have been
mixed into the PCL matrix directly.16–19
Nevertheless, to date, only a slight improvement in compres-
sive modulus and yield strength was achieved with PCL/ceramic
composite scaffolds compared with those of PCL scaffolds. As
an example, PCL/tricalcium phosphate (TCP) composite scaf-
folds exhibited a compressive modulus of 9.3 MPa and
compressive yield strength of 3.1 MPa, while PCL scaffolds
exhibited a compressive modulus of 2.7 MPa and compressive
yield strength of 1.5 Mpa.18 These PCL/TCP scaffolds are
remarkably weak for cancellous bone tissue engineering. As
reported recently in the review paper by Rezwan K. et al., the
limited improvement on mechanical properties of polymer/
ceramic composite scaffolds is because of the relatively low
interfacial bonding between ceramic filler and polymer matrix.9
Another study has also demonstrated that effective stress trans-
fer across the interface between polymer and ceramic filler is
crucial for producing composite scaffolds with adequate
mechanical properties.20
Good osteoconductive property is another crucial requirement
of ideal scaffolds for bone tissue engineering.7,21 Though the
incorporated ceramic particles were supposed to improve the
osteoconductive property of the composite scaffolds,18 the limited
exposure of ceramics on the composite scaffold surface diminishes
this.22 The limited exposure may be due to enveloping of ceramic
particles by polymer during composite preparation and/or the
scaffold fabrication process. Therefore, to improve the osteo-
conductive property of polymer/ceramic composite scaffolds,
a layer of apatite coating on the scaffolds surface is considered as
an effective approach. However, a previous study on melt extru-
sion based AM scaffolds coated with apatite did not find any
promising result due to flaking of the thick apatite layer on the bars
of scaffolds.23 To reduce the flaking tendency a composite coating
may be desirable. A recent study indicated that apatite/collagen
composite coating has a significantly higher coating retention on
titanium compared to pure apatite coating.24
Here, high performance additive manufactured PCL/TCP(Si)
scaffolds have been developed for cancellous bone tissue engi-
neering. Firstly, TCP was modified using 3-glycidoxypropyl tri-
methoxysilane (GPTMS) to enhance the interfacial bonding
between TCP and PCL matrix. To ensure the formation of
covalent bonding between TCP(Si) and PCL, the compoundedSoft MatterPCL/TCP(Si) composites was annealed at 120 C for 2 h. Melt
extrusion based AM PCL/TCP(Si) scaffolds were then fabricated
using an in-house screw extrusion system (SES) from the rein-
forced PCL/TCP(Si) composite. Secondly, carbonated
hydroxyapatite (CHA)-gelatin composite was coated onto AM
PCL/TCP(Si) scaffolds through a biomimetic co-precipitation
process to improve their osteoconductive property. Studies on
cell-scaffold interaction were carried out by culturing porcine
bone marrow stromal cells (BMSCs) on the scaffolds and
assessing proliferation, bone related gene and protein expression
capabilities of the BMSCs. We hypothesized that such developed
CHA-gelatin composite coated PCL/TCP(Si) scaffolds would
provide not only adequate mechanical properties but also an
excellent biocompatible environment to cells for better prolifer-
ation and osteogenic differentiation.Results and discussions
PCL/TCP(Si) composite preparation and scaffolds fabrication
In order to prepare additive manufactured PCL/TCP scaffolds
with adequate mechanical properties for cancellous bone tissue
engineering, the interfacial bonding between PCL and TCP was
enhanced by modifying TCP using GPTMS as a coupling agent.
The main idea is that the epoxide group from GPTMS attached
to TCP could react with the end groups of the PCL chain (OH
and COOH) to form a covalent bond during melt-compounding
and the followed annealing. Fig. 1 shows the schematic diagram
of TCP modification as well as the covalent bond formation
between TCP(Si) and PCL. First, hydroxyl groups were intro-
duced onto TCP by stirring its suspension in a diluted phos-
phoric acid (2 wt%) for 2 h as reported previously.25 Then,
GPTMS was covalently bonded onto the surface of TCP via
a condensation reaction with the introduced hydroxyl group on
TCP. The successful modification of TCP was verified by X-ray
photoelectron spectroscopy (XPS) and Fourier transform
infrared spectroscopy (FTIR). As shown in Fig. 2, while only
calcium, phosphorous and oxygen are detected on the surface of
the non-treated TCP using XPS, additional silicon peaks (Si(2p):
99.8 eV; and Si(2s): 149.7 eV) from GPTMS are observed in the
XPS spectrum of TCP(Si), confirming the presence of GPTMS
on TCP. In the FTIR spectrum of TCP(Si) (Fig. 3b), observation
of an additional characteristic epoxide band at 873 cm1 inThis journal is ª The Royal Society of Chemistry 2011
Fig. 2 XPS spectra of (a) TCP and (b) TCP(Si).
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View Onlinecomparison to that of TCP also confirms the presence of
GPTMS on TCP(Si). TCP(Si) with varying concentration of
GPTMS was synthesized to study the influence of GPTMS
content on the mechanical property of PCL/TCP(Si) scaffolds.
The synthesized TCP(Si) was suspended in acetone and mixed
into PCL acetone solution by homogenizing at high speed. After
evaporating off acetone using a rotary evaporator, the PCL/TCP
(Si) composite was melt-compounded at 120 C for 20 min fol-
lowed by annealing at 120 C for 2 h to facilitate the formation of
covalent bonds between epoxide from TCP(Si) and OH or
COOH from PCL. A similar chemical reaction has been reported
previously.26,27
Additive manufactured PCL/TCP(Si) scaffolds (Fig. S1†) were
fabricated from the above synthesized PCL/TCP(Si) composite
using an in-house screw extrusion system (SES). SES is a poten-
tial melt extrusion based AM technology and has been used to
fabricate scaffolds with specifically tailored pore geometry and
architectural pattern.17 In this study, the fabricated scaffolds
were 100% interconnected with a pore size of 750–950 mm and an
overall porosity of 65%. Additive manufactured PCL/TCP
scaffolds with the same dimension were also fabricated as
controls.
The compressive modulus and yield strength of PCL/TCP(Si)
scaffolds with varying content of GPTMS were measured byFig. 3 FTIR spectra of (a) TCP and (b) TCP(Si).
This journal is ª The Royal Society of Chemistry 2011compression testing, and compared with those of PCL/TCP
scaffold. As shown in Fig. 4, both compressive modulus and yield
strength of PCL/TCP(Si) scaffolds are significantly higher than
those of the PCL/TCP scaffold, and PCL/TCP(Si) scaffold with
10 wt% of GPTMS with respect to TCP exhibits the maxima
compressive modulus of 82.6 MPa and a compressive yield
strength of 4.0 MPa, which are 6.0 and 2.3 times of those of PCL/
TCP scaffolds, respectively. A slight reduction in the modulus at
GPTMS of 15 wt% or higher might be due to formation of a thin
layer of polysiloxane condensed from GPTMS on the surface of
TCP, which works as a plasticizer to reduce the modulus. It
should be noted that both the compressive modulus and yield
strength of PCL/TCP(Si) scaffolds with a GPTMS content
higher than 5 wt% fall in the lower range of mechanical prop-
erties of cancellous bone (50 to 500 MPa and 3 to 12 MPa),
whereas the PCL/TCP scaffolds are remarkably weaker. As PCL/
TCP(Si) scaffold with 10 wt% of GPTMS with respect to TCP
exhibits the best mechanical properties, it has been chosen for
coating and in vitro evaluation, and is denoted as PCL/TCP(Si).
PCL is a semi-crystalline polymer, and the crystallinity degree
of PCL in PCL/TCP and PCL/TCP(Si) with various GPTMS
content were measured using differential scanning calorimeter
(DSC) and the results were listed in Table 1. It was found that the
crystallinity degree of PCL in PCL/TCP(Si) with various
GPTMS content is much higher than that in PCL/TCP. This may
be due to the enhanced interfacial bonding between TCP(Si) and
PCL, leading to higher nucleating efficiency of TCP(Si) for theFig. 4 Compressive modulus (a) and compressive yield strength (b) of
PCL/TCP and PCL/TCP(Si) scaffolds with various content of GPTMS
on TCP (* indicates p < 0.05). 0 wt% of GPTMS to TCP refers to PCL/
TCP.
Soft Matter
Table 1 Thermal property of PCL/TCP(Si) composites determined by
DSC
wt% of
GPTMS to TCP Melting T/C Crystallinity (%)
0 55.3 39.9
5 55.0 47.2
10 55.1 47.7
15 54.8 46.4
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View Onlinecrystallization of PCL. This increase in the crystallinity degree is
correlated with the enhancement in compressive modulus and
yield strength.28 But, the melting temperature seemed to be
independent of the introduction of GPTMS.Biomimetic CHA-gelatin composite coating on PCL/TCP(Si)
scaffolds
Natural bone extracellular matrix (ECM) mainly consists of
collagen and carbonated hydroxyapatite (CHA) composite.29 In
comparison to collagen, collagen-based gelatin has almost an
identical composition and is much cheaper.30 Since gelatin is
denatured, it also overcomes the possible risk of immunogenicity
and pathogen transmission associated with collagen. Hence, to
improve the osteoconductive property of the additive manufac-
tured PCL/TCP(Si) scaffolds, a CHA-gelatin composite was
coated onto the scaffolds through a biomimetic co-precipitation
process.
In order to facilitate biomimetic mineralization on the surface
of the PCL/TCP(Si) scaffolds, CaHPO4 was coated onto their
struts first as a nucleation site for CHA coating or CHA-gelatin
composite coating by dipping NaOH treated scaffolds alter-
nately in calcium chloride and potassium phosphate solutions, as
reported previously.31 To prepare CHA-gelatin composite coated
PCL/TCP(Si) scaffolds (PCL/TCP(Si)-CHA-gelatin), the
CaHPO4 coated PCL/TCP(Si) scaffolds were then immersed into
gelatin acetic acid solution followed by simultaneously adding
dropwise CaCl2 and H3PO4 aqueous solutions, and further
dropwise addition of Na2CO3 aqueous solution according to the
approach for CHA-gelatin composite preparation as reported
previously.32 The carboxyl and amine groups present in the
gelatin may become charged groups under the coating condi-
tions, such as COO and NH3
+, which promote CHA-gelatin
composite formation. It should be noted that the CHA-gelatin
composite coating is free of chemical cross-linking with gelatin.
Thus, this approach avoids the risk of toxicity caused by chem-
icals employed for cross-linking gelatin in other approaches.33,34Fig. 5 SEM images of (a) PCL/TCP(Si), (b) PCL/TCP(S
Soft MatterBy the biomimetic approach described here, mineralization can
be achieved in just a few hours, whereas conventional minerali-
zation may take a few weeks.35,36 Moreover, unlike the conven-
tional biomimetic approach, the developed process does not
demand a constant pH to maintain supersaturation for apatite
crystal growth. PCL/TCP(Si) scaffolds coated with CHA alone
(PCL/TCP(Si)-CHA) were also prepared following the same
process without adding gelatin to study the influence of gelatin
incorporation on the osteoconductive property of the scaffolds.
The surface morphology of the PCL/TCP(Si), PCL/TCP(Si)-
CHA and PCL/TCP(Si)-CHA-gelatin scaffolds was character-
ized by using SEM. As shown in Fig. 5, while the PCL/TCP(Si)
scaffolds exhibits a smooth surface, both the PCL/TCP(Si)-CHA
and PCL/TCP(Si)-CHA-gelatin scaffolds exhibit rough surfaces
with uniform coating throughout the whole surface. The CHA
coating looks like globular apatite (Fig. 5b) and the CHA-gelatin
composite coating looks like plate-like apatite (Fig. 5c). The
morphology difference between the CHA coating and CHA-
gelatin composite coating could be due to the presence of gelatin
in the biomimetic co-precipitation for the CHA-gelatin
composite coating, as it is known that adsorption of protein on
the mineral surface can alter the nucleation and growth of
crystals in biomineralization.37 The thickness of the CHA coating
and the CHA-gelatin composite coating are measured as 702 
56 nm and 635  119 nm from their cross-section SEM images,
respectively (Fig. S2†).
Compression testing of the CHA and CHA-gelatin coated
scaffolds was also conducted and the results demonstrated that
coating does not influence the mechanical properties of the PCL/
TCP(Si) scaffolds (Fig. S3†).
The chemical structure of the coating was studied by using
XPS. No characteristic peaks of calcium and phosphorous
detected in the XPS spectrum of PCL/TCP(Si) scaffolds (Fig. 6a)
implies that ceramic particles of TCP(Si) are covered by PCL
during composite preparation and/or scaffold fabrication as
reported previously.22 In contrast, characteristic peaks of calcium
and phosphate are observed in the XPS spectra of both PCL/
TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds. More-
over, a nitrogen peak is detected in the XPS spectrum of PCL/
TCP(Si)-CHA-gelatin scaffolds (Fig. 6d). All these confirm the
successful formation of CHA and CHA-gelatin coating on the
strut surface of PCL/TCP(Si) scaffolds.
In vitro cells response
The cell-scaffold interaction is crucial for tissue engineering, and
an ideal scaffold provides a suitable environment for cells to
proliferate and differentiate. BMSCs have self-renewali)-CHA and (c) PCL/TCP(Si)-CHA-gelatin scaffolds.
This journal is ª The Royal Society of Chemistry 2011
Fig. 6 XPS spectra of (a) PCL/TCP, (b) PCL/TCP(Si), (c) PCL/TCP
(Si)-CHA and (d) PCL/TCP(Si)-CHA-gelatin scaffolds.
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View Onlinecapability, multilineage differentiation potential and a similar
prospect as embryonic stem cells, but they are less related with
ethical issues and tumorigenesis risks.38 Therefore, BMSCs have
been widely employed for in vitro studies of bone formation and
evaluating the biocompatibility of a newly developed material for
bone tissue engineering.38–40 In this study, the proliferative and
osteoconductive properties of the prepared scaffolds are evalu-
ated by observing BMSCs morphology, proliferation, and gene
and protein expression.
Fig. 7 shows the SEM images of BMSCs cultured onPCL/TCP,
PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-
gelatin scaffolds at day 7. Highest level of cells and cell-sheet
accumulation were observed on PCL/TCP(Si)-CHA-gelatin
scaffolds among all the scaffolds. Moreover, from the overview
image of the PCL/TCP(Si)-CHA-gelatin scaffolds it can be seen
that tissue bridges have started to form (indicated by arrow in
Fig. S4†). On the other hand, for both PCL/TCP and PCL/TCP
(Si) scaffolds the cells spread in a comparatively limited manner.Fig. 7 SEM images of cell-scaffold construct of (a) PCL/TCP, (b) PCL/
TCP(Si), (c) PCL/TCP(Si)-CHA and (d) PCL/TCP(Si)-CHA-gelatin
scaffolds at day 7. The arrow shows the cells and/or cell-sheet accumu-
lation that have spread on the surface of the scaffolds.
This journal is ª The Royal Society of Chemistry 2011Fig. 8 shows the confocal laser microscopy image of BMSCs
cultured on PCL/TCP, PCL/TCP(Si), PCL/TCP(Si)-CHA and
PCL/TCP(Si)-CHA-gelatin scaffolds at different culture times.
At day 7, BMSCs stretched well over the struts and distributed
uniformly in PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-
gelatin scaffolds, while qualitatively fewer BMSCs were observed
in non-coated PCL/TCP and PCL/TCP(Si) scaffolds. At day 10,
PCL/TCP(Si)-CHA-gelatin scaffolds exhibited tissue bridges
between the struts (Fig. 9) as well as the most uniform distribu-
tion of viable cells among all the scaffold groups (Fig. 8). In
contrast, at day 10, the BMSCs seeded in PCL/TCP and PCL/
TCP(Si) scaffolds were predominantly in a round shape. It
should be noted that our developed thin CHA-gelatin composite
coating did not show any flaking tendency during cell culture as
opposed to previous study,23 demonstrating excellent adhesion of
the biomimetic composite coating to the scaffolds.
Fig. 10 shows the proliferation of BMSCs in the cell-scaffold
constructs studied by PicoGreen assay. At all the time points,
coated PCL/TCP(Si) scaffolds exhibit a higher amount of DNA
in comparison to non-coated PCL/TCP and PCL/TCP(Si) scaf-
folds. At day 7, PCL/TCP(Si)-CHA-gelatin scaffolds exhibit
significantly higher amounts of DNA in comparison to non-
coated PCL/TCP and PCL/TCP(Si) scaffolds. At day 10, both
PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds
exhibit significantly higher amounts of DNA in comparison to
non-coated PCL/TCP and PCL/TCP(Si) scaffolds, and the
significantly highest amount of DNA content is exhibited by
PCL/TCP(Si)-CHA-gelatin scaffolds among all the scaffolds,
with a 1.4 and 2.0 times higher value than that of PCL/TCP(Si)-
CHA and PCL/TCP(Si) scaffolds, respectively. These findings
signify the highest level of BMSCs proliferation on PCL/TCP
(Si)-CHA-gelatin scaffolds among all the scaffold groups, which
could be due to the presence of gelatin in CHA-gelatin composite
coating. Gelatin is recognized to promote cell proliferation.41 In
addition, PCL/TCP and PCL/TCP(Si) scaffolds exhibited an
almost similar amount of DNA content for all the time points.
This demonstrates that PCL/TCP and PCL/TCP(Si) scaffolds
posses almost the same level of biocompatibility, indicating
GPTMS modification on TCP does not lead to any detrimental
effect on BMSCs activity as reported previously on the
biocompatibility of silane treated surface.42–44
The differentiation of BMSCs in the cell-scaffold constructs
was studied by RT-PCR analysis. The quantitative RT-PCR
analysis (Fig. 11) revealed that at day 17, PCL/TCP(Si)-CHA-
gelatin and PCL/TCP(Si)-CHA scaffolds have 6.2 and 3.8 times
higher expression levels of Core binding factor a1 (Cbfa1) than
that of PCL/TCP(Si) scaffolds, respectively. At day 24, which is
a later time point, the Cbfa1 expression levels of PCL/TCP(Si)-
CHA-gelatin and PCL/TCP(Si)-CHA scaffolds were 1.4 and 4.3
times higher than that of PCL/TCP(Si) scaffolds, respectively.
Cbfa1 is considered as an important transcription factor for the
commitment of multipotent mesenchymal cells into the osteo-
blastic lineage by triggering the gene expression of bone matrix
proteins.44,45 Cbfa1 retains the osteoblastic cells at an immature
stage by hampering the transition of osteoblasts to osteocytes.
Generally, the expression of Cbfa1 is first noticed in preosteo-
blasts, and up regulated in immature osteoblasts, but down
regulated in mature osteoblasts.45,46 Cbfa1 is also involved in
regulating bone phenotypic genes such as osteocalcin (OCN),Soft Matter
Fig. 8 Confocal laser microscopy with depth projection images reconstructed from multiple horizontal images, showing 3D distribution of cells within
the scaffolds of PCL/TCP, PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds.
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View Onlineone of the terminal differentiation markers.45,47,48 It can be seen
from Fig. 11, from day 17 to day 24, OCN increases from 4.2
times higher to 25.2 times higher for PCL/TCP(Si)-CHA-gelatin
scaffolds than that of the PCL/TCP(Si) scaffolds, while the
Cbfa1 decreases from 6.2 times higher to 1.4 times higher.
Expression of collagen I (Col1) showed slightly basal expression
levels for PCL/TCP(Si)-CHA-gelatin and PCL/TCP(Si)-CHA
scaffolds compared to PCL/TCP(Si). Though the reason behind
this phenomenon is not clear yet, basal regulation of Col1
expression of marrow stromal cells (MSC) on hydroxyapatiteFig. 9 Confocal laser microscopy image of PCL/TCP(Si)-CHA-gelatin
scaffolds at day 10, showing a tissue bridge as indicated by the arrow.
Soft Matterafter day 10 has also been reported previously.49,50 From the
above results it can be concluded that though cells express almost
similar amount of Col1 transcription, they show significantly
more expression of mature ostoegenic gene OCN for coated
scaffolds, which eventually indicate that the cells on the coated
PCL/TCP(Si) scaffolds are more in the osteogenic lineage.
To analyze the extracts of protein formed on cell-scaffold
constructs, western blotting was carried out after BMSCs were
cultured for 31 days. Osteonectin (ON) is an important non-
collagen calcium binding glycoprotein related to mineralisation at
the early stage of bone formation secreted by osteoblasts. As can be
seen from Fig. 12, the expression of ON is 2.5 and 2.2 times higher
on PCL/TCP(Si)-CHA-gelatin and PCL/TCP(Si)-CHA scaffoldsFig. 10 PicoGreen DNA quantification results of BMSCs cultured on
PCL/TCP, PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-
gelatin scaffolds (* indicates p < 0.05).
This journal is ª The Royal Society of Chemistry 2011
Fig. 11 mRNA expression of Cbfa1, collagen I (Col1) and osteocalcin
(OCN) of BMSCs cultured for 17 days and 24 days on PCL/TCP, PCL/
TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-CHA-gelatin scaffolds
(* indicates p < 0.05).
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View Onlinecompared to that on PCL/TCP(Si) scaffolds, respectively. OCN is
a bone-specific glycoprotein found abundantly in bone and dentin.
This non-collagenous protein is secreted by osteoblasts. It is known
to promote calcification of the bone matrix, and has been studied
as a late marker for osteogenic differentiation and osteoblast
maturation38,45,51 The expression of OCN is 1.2 and 1.3 times
higher on PCL/TCP(Si)-CHA-gelatin and PCL/TCP(Si)-CHA
scaffolds than that on PCL/TCP(Si) scaffolds, respectively.Fig. 12 Protein extracts of osteonectin (ON), osteopontin (OPN) and
osteocalcin (OCN) from cell-scaffold constructs after BMSCs were
cultured for 31 days on PCL/TCP, PCL/TCP(Si), PCL/TCP(Si)-CHA
and PCL/TCP(Si)-CHA-gelatin scaffolds.
This journal is ª The Royal Society of Chemistry 2011Osteopontin (OPN) is another mineral-binding protein found in
bone extracellular matrix and is associated with cell attachment,
proliferation, and biomineralization of extracellular matrix into
bone. Its expression exhibits the commitment of BMSCs to oste-
ogenic differentiation.51 A significantly higher level (5.7 times) of
OPN expression was observed on PCL/TCP(Si)-CHA-gelatin
scaffolds compared to that on PCL/TCP(Si) scaffolds. At the same
time, PCL/TCP(Si)-CHA scaffolds showed 4.7 times higher OPN
expression compared to PCL/TCP(Si) scaffolds. Fig. 12 also
showed a higher amount of ON and OPN expression on PCL/TCP
(Si)-CHA-gelatin scaffolds than that on PCL/TCP(Si)-CHA scaf-
folds. Stimulation of osteogenic differentiation of BMSCs on PCL/
TCP(Si)-CHA-gelatin scaffolds may be due to the presence of
gelatin in the CHA-gelatin composite coating.52 A previous study
on collagen and HA showed that the addition of collagen to
hydroxyapatite implants can enhance both phagocytotic and
osteogenic processes.53 These results suggest that CHA-gelatin
composite coating on PCL/TCP(Si) scaffolds improved the
proliferation and osteoconductive capability of the scaffolds
significantly.
Conclusions
Additive manufactured PCL/TCP(Si) scaffolds with enhanced
mechanical and osteoconductive properties have been success-
fully prepared. TCP was modified by using GPTMS and the
modified TCP has been incorporated into PCL to form a rein-
forced PCL/TCP(Si) composite through homogenization fol-
lowed by melt compounding and annealing at 120 C for 2 h. The
successful modification of TCP was verified by XPS and FTIR
analysis. Additive manufactured PCL/TCP(Si) scaffolds with
100% interconnectivity and 65% porosity were fabricated using
an in-house SES. The PCL/TCP(Si) scaffolds showed a 6.0 times
higher compressive modulus and 2.3 times higher compressive
yield strength than those of PCL/TCP scaffolds and eventually
match with the lower range mechanical properties of cancellous
bone. The osteoconductive property of the PCL/TCP(Si) scaf-
folds was improved by coating with CHA-gelatin composite via
a biomimetic co-precipitation process, which was verified by XPS
analysis. SEM and confocal images demonstrated the highest
level of cells and cell-sheet accumulation with the most uniform
distribution on PCL/TCP(Si)-CHA-gelatin scaffolds, compared
to all other scaffolds. The proliferation rate of BMSCs on CHA-
gelatin composite coated PCL/TCP(Si) scaffolds were 2.0 and 1.4
times higher than that of PCL/TCP(Si) and CHA coated PCL/
TCP(Si) scaffolds, respectively, by day 10. In vitro RT-PCR and
western blotting testing showed the highest level of osteo-
conductive property on PCL/TCP(Si)-CHA-gelatin compared to
all other scaffolds. Moreover, no negative effects of GPTMS
modification was noticed. This study clearly extends the potential
of melt extrusion based additive manufactured composite scaf-
folds for bone tissue engineering applications.
Experimental
Materials
Poly(3-caprolactone) (PCL) (Mn: 80,000), 3-glycidoxypropyl
trimethoxysilane (GPTMS), gelatin (type A, from porcine skin),
acetic acid (CH3COOH), calcium chloride (CaCl2), potassiumSoft Matter
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View Onlinehydrophosphate (K2HPO4), phosphoric acid (H3PO4, 85%
solution in water), sodium carbonate (Na2CO3) and sodium
hydroxide (NaOH) were purchased from Sigma-Aldrich, Singa-
pore. Tri-calcium phosphate (TCP) was purchased from Pro-
gentix, The Netherlands.
Synthesis of PCL/TCP(Si)
Surface activation of TCP was carried out by stirring TCP in 2%
phosphoric acid (1 : 2 w/w) at room temperature for 2 h followed
by sonicating for 5 min.25 The surface activated TCP was washed
first with distilled water for 3 times to remove free phosphoric
acid and then with acetone for 3 times to remove water, and
suspended in actone. GPTMS was then added into TCP acetone
suspension and refluxed at 75 C for 24 h. GPTMSmodified TCP
(TCP(Si)) was collected through filtration followed by a thor-
ough wash with acetone to remove free GPTMS. The TCP(Si)
was incorporated into PCL through homogenizing PCL/TCP(Si)
acetone solution at 8000 rpm for 15 min. After evaporating off
acetone, the homogenized composite was vacuum dried at 50 C
for 1 week. Finally, PCL/TCP(Si) composite was melt com-
pounded at 120 C for 20 min and annealed at 120 C for 2 h.
Fabrication of the PCL/TCP(Si) scaffolds by SES
Additive manufactured PCL/TCP(Si) composite scaffolds were
fabricated using an in-house screw extrusion system (SES) with
screw rotational speed of 25 rpm and nozzle diameter of 0.4 mm
at a processing temperature of 85 C. The dispensing speed of the
machine was 4 mm s1 and the center to center distance of the
scaffold struts was set to 1.5 mm. Each layer of the scaffolds was
fabricated with the designed pattern of 0/60/120 orientation.
The size of the scaffolds used for mechanical test was 5 mm  5
mm  8 mm and for the cell culture was 5 mm  5 mm  3.5
mm. The reason of choosing relatively lower height scaffolds is to
use the available resources efficiently. PCL/TCP scaffolds were
also fabricated as control.
Surface coating on PCL/TCP(Si) scaffolds
As PCL/TCP(Si) scaffold with 10 wt% of GPTMSwith respect to
TCP exhibits the best mechanical properties; therefore, it has
been used for coating and in vitro evaluation and is denoted as
PCL/TCP(Si). The PCL/TCP(Si) scaffolds were immersed in
aqueous NaOH solution (10 ml, 5 M) at room temperature for 12
h followed by thorough washing with de-ionized water. The
NaOH treated scaffolds were dipped into calcium chloride
solution and potassium hydrophosphate solution alternately to
achieve CaHPO4 coating.
31 In detail, the scaffolds were initially
dipped in CaCl2 aqueous solutions (20 mL, 0.2 M) for 10 min,
and then dipped in de-ionized water for 5 s followed by air drying
for 3 min. The treated scaffolds were subsequently dipped in
K2HPO4 aqueous solutions (20 mL, 0.2 M) for 10 min, and then
dipped in de-ionized water for 5 s followed by air drying for 3
min. The whole process was repeated three times.
The CaHPO4 coated PCL/TCP(Si) scaffolds were immersed
into CH3COOH (20 ml, 0.1 M), and then CaCl2 (10 ml, 0.1 M)
and H3PO4 (6 ml, 0.1 M) with a Ca/P ratio of 1.66 were gradually
added through respective syringe pumps under stirring. After 30
min of stirring, Na2CO3 (18 ml, 0.1 M) with the molar ratio ofSoft MatterCO3
2/PO4
3 of 3 was gradually added. The mixture was further
stirred for another 30 min and then titrated to pH 9 using NaOH
(0.1 M). After the solution was aged for 3 h, the CHA coated
PCL/TCP(Si) scaffolds (PCL/TCP(Si)-CHA) were taken out,
washed with de-ionized water and freeze dried.
For preparing CHA-gelatin composite coated PCL/TCP(Si)
scaffolds, CaHPO4 coated PCL/TCP(Si) scaffolds were
immersed into CH3COOH (10 mL, 0.1 M) solution dissolved
with gelatin (40 mg). Then, CHA-gelatin composite coated PCL/
TCP(Si) (PCL/TCP(Si)-CHA-gelatin) scaffolds were achieved by
adding CaCl2, H3PO4, Na2CO3 and NaOH following the same
process as that of CHA coating described above.Characterization
The surface chemical structure of TCP(Si) and PCL/TCP(Si)
scaffolds were characterized by XPS (Thetaprobe from Thermo
Scientific), using a source of monochromated Al Ka (1486.6 eV)
along with a flood gun for surface charge compensation (energy 2
eV, emission current 100 mA). The detector was set at standard
lens mode CAE (contact analyzer energy) and passed energy for
survey spectra is 200 eV and 40 eV for high resolution spectra.
Data analysis was done using the Avantage software. FTIR
spectra of TCP and TCP(Si) minced into the KBr pallet were
recorded on a Bio-Rad 165 FT-IR spectrophotometer; 64 scans
were signal-averaged with a resolution of 2 cm1 at room
temperature. Differential scanning calorimetry (DSC) measure-
ments were performed using a TA Instruments 2920 differential
scanning calorimeter equipped with an auto-cooling accessory
and calibrated using indium. The following protocol was used for
each sample: heating from room temperature to 120 C at 20 C
min1, holding at 120 C for 2 min, cooling from 120 to30 C at
5 C min1, and finally reheating from 30 to 170 C at 5 C
min1. Data were collected during the second heating run. The
degree of crystallinity was calculated according to the following
equation:
Crystallinity (%) ¼ (DHm/(80%)/DHm)  100%; where Hm is
the melting enthalpy (J g1) of composite; 80% is the weight
percentrage of PCL in the composite and DHm
 (139.5 J g1) is
the melting enthalpy of 100% crystalline PCL.54
Compressive modulus and compressive yield strength of the
scaffolds were measured using an Instron 4502 uniaxial testing
system with 5 kN load cell. All scaffolds had the size of 5 mm 5
mm  8 mm and 0/60/120 lay down patterns. Ten scaffolds
were tested from each group and measurements were reported as
mean  standard deviation.
The surface morphology of the scaffolds was studied with
a Quanta 200F field emission scanning electron microscope
(FESEM) at a beam intensity of 10 kV after gold sputtering using
a JFC-1200 fine sputter coater.Cell seeding on scaffolds
Tissue culture media Dulbecco’s modified Eagle’s medium
(DMEM), fetal bovine serum (FBS) and penicillin-streptomycin
(pen-strep) were purchased from Gibco. Trypsin-EDTA was
purchased from Thermo Scientific Hyclone.
Cryo-preserved porcine BMSCs (passage 2) were isolated from
the iliac crest of pigs and expanded in T75 tissue culture flasks inThis journal is ª The Royal Society of Chemistry 2011
Table 2 Forward primers and reverse primers used in RT-PCR
Gene ID Forward Primer Reverse Primer
GAPDH GCTTTGCCCCGCGATCTAATGTTC GCCAAATCCGTTCACTCCGACCTT
CBFA1 GAGGAACCGTTTCAGCTTACTG CGTTAACCAATGGCA CGA G
COL1 CCAAGAGGAGGGCCAAGAAGAAGG GGGGCAGACGGGGCAGCACTC
OCN TCAACCCCGACT GCGACGAG TTGGAGCAGCTG GGATGATGG
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View OnlineDMEM supplemented with 10% FBS and 1% antibiotics until
getting sufficient cells (not beyond passage 4). Medium was
changed twice a week and cells were detached by trypsin-EDTA
and transferred into fresh culture flasks at a ratio of 1 : 3 upon
reaching confluence. Cultures were incubated at 37 C in
a humidified atmosphere with 5% CO2.
To sterilize the scaffolds, first the scaffolds were treated with
ethanol (70%) for 30 min and then treated under UV light for 30
min followed by drying in sterile condition at room temperature
for 2 h. Four groups of scaffolds were prepared namely, PCL/
TCP, PCL/TCP(Si), PCL/TCP(Si)-CHA and PCL/TCP(Si)-
CHA-gelatin, and BMSCs (1.8  105 cells) were added onto each
scaffold. The cell-scaffold constructs were cultured up to 10 days
in growth medium, and at specific time points cell-scaffold
constructs were assessed and observed for proliferation. For
osteogenic induction, after 10 days of culture in growth medium,
an osteogenic cocktail of dexamethasome (10 nM), ascorbic acid
(50 mM) and b-glycerolphosphate (10 mM) (Sigma) was added.
The cell-scaffold constructs were cultured further for 28 days
post induction and samples were assessed at definite time points
for gene and protein expressions.Morphology of the cell-scaffold constructs
SEM and confocal laser microscopy were used to assess cell
morphology, viability and attachment in vitro. BMSCs were
stained with fluorescein diacetate (FDA) (2 mg ml1) (Molecular
probes), which stains the cytoplasm of the live cells with green
fluorescence. During FDA staining samples were incubated at
37 C for 15 min followed by rinsing with PBS. Samples were
then counterstained with propidium iodide (PI) (5 mg mL1)
(Molecular probes) to stain the nucleus of the dead cells with red
fluorescence. During PI staining the samples were kept at room
temperature for 2 min and then rinsed with PBS. Finally the
samples were viewed under confocal laser microscope (IX 70,
Olympus). Depth projection images were constructed from up to
25 horizontal image sections (12 mm each) through the stained
cell-scaffold constructs using FV1000 Viewer (Ver.1.7a) soft-
ware. After confocal imaging, cell-scaffold constructs were fixed
in formalin (10%) overnight and then dehydrated through
a series of graded ethanol solutions (5, 10, 20, 40, 60, 80, 90 and
100%), each for 10 min for dehydration. Finally, the samples
were dried overnight at room temperature and were gold sput-
tered to observe under SEM at an accelerating voltage of 10 kV.PicoGreen assay
Proliferation of BMSCs in cultured cell-scaffold constructs were
studied using the PicoGreen assay as per manufacturer’sThis journal is ª The Royal Society of Chemistry 2011protocol (Molecular Probes, PicoGreen dsDNA Quantitation
kit). Total DNA from cells in the constructs were extracted via
freeze-thaw cycles. DNA amount in the cell lysate were then
assayed by mixing with DNA binding PicoGreen dye followed
by spectrophotometer quantisation.Gene expression (Real-time RT-PCR)
At specified time points, the cell-scaffold constructs were lysed
with Trizol (Invitrogen) and thoroughly vortexed. The samples
in Trizol were stored at 80 C until RNA isolation. Total RNA
was isolated using the RNeasy Mini Kit (Qiagen) with Rnase-
Free DNase (Qiagen) according to the manufacturer’s protocol.
Reverse transcription was performed with the QuantiTect
Reverse Transcriptase kit (Qiagen) to make the required cDNA.
Quantitative PCR was performed for the quantification of gene
expressions using the primers listed in Table 2 and QuantiTect
SYBR Green PCR kit (Qiagen) Mx3000P Real-Time PCR
System (Stratagene). Target genes were normalized against the
GAPDH expression.Western blot study (WB)
Protein extracts were harvested from the cell-scaffold constructs
with ice-cold radioimmunoprecipitation assay (RIPA) buffer
(Thermo Scientific). As the protein level from a single scaffold is
usually too small for a gel run, the protein extracts were collected
from 5 samples per group to get a more concentrated protein
extract. The testing results are reported as an average of 5
samples. Protein lysates were purified and concentrated using
NanoSep columns (Pall 3 K). Total protein quantity was quan-
tified using microBCA assay (Pierce) as per manufacture’s
protocol. Proteins were denatured at 90 C for 5 min, resolved by
10% SDS-PAGE (polyacrylamide gel electrophoresis) and
transferred to nitrocellulose membranes (Bio-Rad). After
blocking with 1% non-fat milk in tris-buffered saline (TBS) for 1
h, the membranes were then incubated for 1 h with primary
antibodies: polyclonal rabbit-anti-human beta-actin (Delta
Biolabs), osteonectin (ON), osteocalcin (OCN) (Santa Cruz) or
osteopontin (OPN) (Abcam). The primary antibodies were
diluted from 1 : 500 to 1 : 2000 in TBS with 0.1% Tween (TBST).
After three washes with TBST, membranes were next incubated
with rabbit anti-goat HRP-conjugated secondary IgG (Zymed)
at 1 : 15,000 for 1 h, followed by another three washes with
TBST. Immunoreactive bands were visualised and detected using
the SuperSignal chemiluminescent reagent (Pierce) on the Ver-
saDoc Imaging Systems (Bio-Rad). The intensities of the bands
were quantitatively analyzed using densitometry (Quantity-One,Soft Matter
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View OnlineBio-Rad). Target proteins were normalized against the b-actin
expression.
Statistical analysis
All the data presented are expressed as mean  standard devia-
tion. An unpaired student’s t-test was used to test the significance
level of the data. Differences were considered statistically
significant at p < 0.05.
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